AGP Executive Report
Last update: 11 hours agoNeurology & Clinical Trials: New real-world and biomarker data from the Peripheral Nerve Society meeting in Maastricht suggest serum neurofilament light chain (sNfL) tracks CIDP activity and falls with efgartigimod, while observational results in Guillain-Barré syndrome (GBS) show IVIg and plasma exchange deliver comparable functional outcomes after adjustment; another GBS study reports similar disability improvement at 4 weeks with efgartigimod versus plasma exchange, but faster muscle strength recovery by weeks 8–12. Oncology: In newly diagnosed FLT3-mutated AML, phase 3 results show gilteritinib delivers overall survival comparable to midostaurin, though the primary end point was not met. Healthcare Policy & Ethics: The Lancet escalates pressure for the World Medical Association to suspend the Israeli Medical Association, citing a petition by healthcare professionals and advocacy groups. Public Health & Access: A Dutch AI startup, OurMind, raised €2.1M to reduce healthcare admin workload, while another AI-in-care push highlights hospitals using AI to cut child mortality. Sports Medicine Angle (Netherlands-linked): World Cup coverage includes injury updates affecting Dutch players and teams, plus a reminder that extreme heat and storms are already disrupting fan safety plans.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
